Signals · cyclerion.com

What just happened at Korsana Biosciences

Last updated

Korsana Biosciences raised $380M Post-IPO Equity on 2026-09-08. It was reported by globenewswire.com.

The evidence, dated and sourced

  1. — Funding: Korsana Biosciences raised $380M Post-IPO Equity.
    Press / news →
  2. — SEC 8-K: Cyclerion disclosed another material event (8-K item 8.01).
    SEC filing →
  3. — SEC 8-K: Cyclerion Therapeutics, Inc. disclosed another material event (8-K item 8.01).
    SEC filing →
  4. — SEC 8-K: Cyclerion changed directors or principal officers (8-K item 5.02).
    SEC filing →
  5. — Funding: Korsana Biosciences raised $175M Series A.
    Press / news →
  6. — SEC 8-K: Cyclerion Therapeutics, Inc. made a Regulation FD disclosure (8-K item 7.01).
    SEC filing →
  7. — SEC 8-K: Cyclerion Therapeutics, Inc. entered a material definitive agreement (8-K item 1.01).
    SEC filing →
  8. — SEC 8-K: Cyclerion Therapeutics, Inc. disclosed another material event (8-K item 8.01).
    SEC filing →

How this is sourced

Every row above links to the document it came from — an SEC filing on EDGAR, or the announcement a publisher ran. Fundz does not paraphrase a source it has not stored, and each row is labelled sec_filing or press_or_news so you can see which you are reading. Funding rounds come from SEC Form D filings and announcements; 8-K events come from the filings themselves. No contact or people data appears here.

Companies with recent events


Get this via API or MCP

The same evidence, as JSON, for your own agents. Quickstart → · MCP endpoint https://api.fundz.net/v1/agent/mcp

curl -s -X POST https://api.fundz.net/v1/agent/why_now \
  -H "X-Fundz-Key: $FUNDZ_KEY" -H "Content-Type: application/json" \
  -d '{"domain": "cyclerion.com"}'